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Abstract
Background: Although studies have shown an association between anxiety and depression and obesity,
psychological health among obese women during and after pregnancy has not been carefully studied. The aim of
this study was to investigate psychological well-being using symptoms of depression and/or anxiety among obese
pregnant women attending a weight gain restriction program and to then compare this group with a control
group receiving traditional antenatal care.
Methods: 151 obese pregnant women in an intervention group and 188 obese pregnant women in a control
group answered the Beck Anxiety Inventory (BAI) and the Edinburgh Postnatal Depression Scale (EPDS). Group
differences between the two groups were estimated by using the c
2 - test on categorical variables. The Student’s
t-test on continuous, normally distributed variables measuring changes in mean score on BAI and EPDS over time
was used. To make a more comprehensive assessment of group differences, between as well as within the two
groups, logistic regressions were performed with the BAI and EPDS as dependent variables, measured at
gestational weeks 15 and 35 and 11 weeks postnatal. The grouping variable has been adjusted for socio-
demographic variables and complications.
Results: The prevalence of symptoms of anxiety during pregnancy varied between 24% and 25% in the
intervention group and 22% and 23% in the control group. The prevalence of symptoms of anxiety postnatally was
9% in the intervention group and 11% in the control group. Five percent of the women in the intervention group
and 4% of the women in the control group showed symptoms of anxiety during the course of pregnancy and at
the postpartum assessment. The prevalence of symptoms of depression during pregnancy varied between 19%
and 22% in the intervention group but was constant at 18% in the control group. Postnatal prevalence was 11% in
both groups. Six percent of the women in the intervention group and 4% in the control group showed symptoms
of depression during the course of pregnancy and at the postpartum assessment. We found no differences
between the two groups as concerns demographic characteristics, weight gain in kg, or the distribution of scores
on anxiety and depressive symptoms nor did we find differences in the fluctuation of anxiety and depressive
symptoms over time between the women in the intervention group and in the control group.
Conclusion: Obese pregnant women attending an intervention program seem to have the same risk of
experiencing anxiety and/or depressive symptoms as do obese pregnant and postnatal women in general.
Background
Obesity has been reported to have a negative impact on
physical health and psychological well-being [1,2]. There
is an association between depression, anxiety and
obesity, and several studies have shown that obese
women are more vulnerable than obese men to the
development of psychiatric and psychological disorders
[3-9]. A number of studies have investigated symptoms
of depression and anxiety during and after pregnancy
[10-13]. Josefsson et al. found in a longitudinal study
that the prevalence of depressive symptoms was 17%
during late pregnancy and 13% postpartum [10].
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pregnancy and 11-14% during the first year postpartum
[12]. Both anxiety and depression during pregnancy are
strong predictors for postpartum depression [11,13].
Obesity during pregnancy is also associated with a
high risk for medical complications [14]. Maternal obe-
sity is, for example, associated with an increased risk for
preeclampsia and gestational diabetes mellitus as well as
for complications during delivery. In addition, there is
an increased risk for antepartum stillbirth and macroso-
mia [14]. Psychological health and well being during and
after pregnancy among obese women have not been
thoroughly investigated. The association between body
mass index (BMI) and self-reported postpartum depres-
sive symptoms was investigated in a study in the United
States [15]. In a stratified random sample of approxi-
mately 600 obese women, 30.8% reported moderate or
greater depressive symptoms compared with 22.8% in a
similar sample consisting of about 1800 normal weight
women, two to six months postpartum. Krause and co-
workers investigated the prevalence of postpartum
depression among approximately 500 overweight and
obese postpartum women, recruited from a randomized
controlled intervention study designed to encourage
postnatal weight loss through increased physical activity
and decreased caloric intake [16]. In this study the pre-
valence of depression was 9.2% and there was no rela-
tionship between BMI and postpartum depression.
In a recent prospective intervention study primarily
designed to minimize obese women’s weight gain to less
than 7 kg during pregnancy, we showed that the women
who received a structured motivational and behavioral
treatment combined with regular physical exercise had a
significantly lower weight gain compared with a control
group of obese pregnant women who received regular
antenatal care without any negative effect on delivery or
neonatal outcome [17]. Since it is known that obesity
can have a negative influence on psychological well-
being, it is important to investigate if the state of psy-
chological well-being of obese pregnant women attend-
ing a weight gain restriction program with a focus on
behavioral changes differs from psychological well being
in a control group. There are to our knowledge no
intervention studies designed to accomplish weight-gain
restriction for obese pregnant women that have also
examined the women’s psychological health status.
We hypothesized that pregnant obese women attend-
ing an intervention program, based on motivational and
behavioral treatment and with the primary aim of redu-
cing weight-gain during pregnancy, would show fewer
depressive and anxiety symptoms throughout pregnancy
and postnatally than women not attending such a pro-
gram. Hence, the aim of this study was to investigate
psychological well-being measured as symptoms of
depression and/or anxiety among obese pregnant
women attending a weight gain restriction program and
to make comparisons with a control group receiving tra-
ditional antenatal care.
Methods
The Swedish antenatal health care system reaches
almost 100% of all pregnant women. The antenatal- and
delivery care are free of charge. At the antenatal care
clinics (ANC) healthy pregnant women are recom-
mended to attend the regular antenatal program with
seven to nine visits to a midwife, and, if needed, arrange
for extra appointments with an obstetrician and/or with
the midwife.
Subjects
During the period November 2003 to December 2005 a
total of 317 obese pregnant women in early pregnancy
were consecutively registered at the ANC in the city of
Linköping and surrounding area. The inclusion criteria
for the study were BMI ≥30 and Swedish-speaking. We
excluded all women with pre-pregnant diagnosis of dia-
betes, thyroid dysfunction or a psychiatric disease trea-
ted with neuroleptic drugs. After excluding women who
did not meet the inclusion criteria, had miscarriage or
legal abortion or moved out from the catchment area in
early pregnancy, 230 women were eligible and invited to
participate. A total of 70 women refrained from partici-
pation and five women dropped out during the interven-
tion. One hundred fifty-five women (67.4%) completed
the intervention. This subsample consisted of 151 obese
women with singleton pregnancies (Figure 1).
All obese pregnant women (n = 437) consecutively
registered during the same period at the ANC in two
nearby cities with surrounding area, formed a control
g r o u p .T h ei n c l u s i o n -a n de x c l u s i o nc r i t e r i aw e r et h e
same as for the intervention women. Thereafter women
who had a miscarriage or legal abortion were excluded.
Finally, 385 women were eligible and invited to partici-
pate. Of this total, 177 women refrained from participa-
tion and 15 women dropped out during pregnancy. One
hundred ninety-three women (50.1%) completed the
participation. This subsample consisted of 188 obese
women with singleton pregnancies (Figure 1).
In a previous study, no differences were found
between the intervention group and the control group
regarding age, parity, marital status, smoking, BMI and
occupation [17]. The women in the intervention group
reported a higher education level than the women in the
control group (p = .044). The women who refrained
from participation in both groups were, on average, one
year younger than the women who participated in the
study (29 vs. 30 years, p = .018). Moreover, those who
declined to participate were smokers and had previous
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the study. For a detailed description of the study partici-
pants, see Claesson et al [17].
All data related to pregnancy, delivery and the puer-
perium were registered in the standardized and identical
Swedish antenatal pregnancy, delivery, and neonatal
records. The data were manually extracted from the
records. This study was approved by the Human
Research Ethics Committee, Faculty of Health Sciences,
Linköping University.
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Figure 1 Description of the study population during the study period.
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The obesity intervention program for pregnant women
was based on extra visits to a specially trained midwife
(author IMC). The women in the intervention group
made an average of 22 visits during their pregnancy.
The motivational interview/talk followed guidelines set
forth by Miller and Rollnick [18]; the goal of this inter-
view was to motivate the obese pregnant woman to
change their behavior and to obtain information useful
in meeting their needs. The weight gain goal for the
study was less than 7 kg and this target was only dis-
cussed once during the intervention and that was at the
first visit to the midwife. The midwife worked through-
out the whole program with assessing the pregnant
woman’s knowledge of obesity in general and as a risk
factor for her pregnancy and delivery outcome as well
as for the wellbeing of her child. If the woman lacked
sufficient knowledge, she was offered information and
given accurate facts. The woman was also informed
about the potential consequences of different behaviors
associated with eating and food intake; written informa-
tion was supplied if needed.
All women were given the opportunity to attend an
individual 30-min session every week. The session
included weight control and counseling characterized by
its collaborative structure i.e. counseling based on creat-
ing a partnership that honors the woman’s expertise and
perspectives and enables the counselor to provide an
atmosphere that is conducive rather than coercive to
change. The woman’s own judgment of her motivation
and the possibility of changing a behavior, the advan-
tages and disadvantages of changing a behavior, the
choice of strategies for adopting and maintaining a new
behavior were all topics of the sessions. All women who
attended the program were also invited to an aqua aero-
b i cc l a s s( o n c eo rt w i c eaw e e k ) ,e s p e c i a l l yd e s i g n e df o r
obese women. The obese women in the control group
attended the routine antenatal care program.
Measures
The Beck Anxiety Inventory (BAI) was used to measure
the severity of anxiety [19]. The BAI consists of a 21-
item self-report inventory where each item describes a
common symptom of anxiety. The BAI discriminate
anxiety from depression [19]. The respondent was asked
to rate each symptom over the preceding week on a
four point scale (0-3). Scores of 0-7 reflect minimal
anxiety, 8-15 mild anxiety, 16-25 moderate anxiety and
score of 26-63 indicate severe anxiety [20]. The upper
interval limit may be adjusted depending on the purpose
for the use. To minimize the rate of false negative
results the upper interval limit may decrease and to
minimize the rate of false positive results the upper
limit may be increased. Some studies have investigated
and validated the BAI in non-clinical samples, composed
of women as well as men [21-23]. The results support
the use of the BAI in a community sample. In this study
we used a cut-off level of ≥10 to define symptoms of
anxiety.
The Edinburgh Postnatal Depression Scale (EPDS) is a
10-item self-report scale assessing symptoms of depres-
sion such as dysphoric mood, anxiety, and feeling of
guilt, suicidal ideas and “not coping”.E a c hi t e mi s
scored on a four point scale (0-3) and rates the intensity
of depressive symptoms during the previous 7 days. The
scale is specifically designed to screen for postpartum
depression but can also be used as a valid measure of
dysphoria through the various stages of pregnancy and
the puerperium [24]. The validity of the Swedish version
has been tested [25]. The EPDS cannot by itself confirm
a diagnosis of depressive illness, but when using a cut-
off level of >12 Cox et al. [24] showed a sensitivity of
86%, a specificity of 78% and a positive predictive value
of 73% for major depressive illness. Another validation
of the EPDS by Murray & Carothers [26] also used a
cut-off level of >12 showed a sensitivity of 68%, a speci-
ficity of 96% and a positive predictive value of 67% for
both major and minor depressive illness. To find all
actual major depressions, Cox et al. [24] propose a cut-
off level ≥10 to reduce detection failure in the postnatal
period. When selecting this threshold the sensitivity for
detection of major depression increased to almost 100%
and the specificity to 82% [27]. In this study we used a
cut-off level of ≥10 to define symptoms of depression.
The women in the intervention- and control group
answered the BAI and the EDPS at around gestational
week 15, 35 and 11 weeks postpartum.
Statistics
All analyses were performed using the SPSS program,
version 16.0 (SPSS Inc., Chicago, IL). Statistical signifi-
cance was defined as (two-sided) p ≤ 0.05. Group differ-
ences between the intervention women and the control
women were estimated by using the c
2 - test on catego-
rical variables. The Student’s t-test on continuous, nor-
mally distributed variables measuring changes in mean
score on BAI and EPDS over time was used. Analyses
were performed between the intervention- and control
g r o u pa sw e l la sw i t h i nt h eg r o u p s .F u r t h e r m o r e ,t o
make a more comprehensive assessment of group differ-
ences, between as well as within the two groups, logistic
regressions were performed with the three BAI and
EPDS measurements as dependent variables. The group-
ing variable has been adjusted for socio-demographic
variables (age, parity, marital status, socioeconomic fac-
tors and occupational status) and complications during
pregnancy (hyperemesis, gestational diabetes mellitus,
preeclampsia, premature contractions, lumbar and pelvic
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tion, instrumental delivery, induced delivery, bleeding
>1000 ml, perineal tears) and neonatal complications
(small for gestational age, preterm <37 weeks, Apgar
Score at 5 min <7 and Apgar Score at 10 min <7).
Results
Anxiety symptoms
In analyses of the anxiety symptoms using the BAI, no
significant differences in the prevalence of symptoms
were found between the groups (Table 1).
Bivariate analysis showed that there was a difference
within the intervention group due to socioeconomic fac-
tors at the time of the two measurements during preg-
nancy (p = .045 and p = .000). Women with a lower
level of education had symptoms of anxiety more often
than the women who had a higher level of education.
The same results were found within the control group
(p = .010 and p = .012). There was also a difference
within the control group at the time of the two mea-
surements during pregnancy concerning occupational
status (p = .003 and p = .009). Women who were unem-
ployed showed symptoms of anxiety more often than
women who were gainfully employed. The multivariate
analyses (logistic regression) showed no difference
between the intervention group and the control group
after adjustment for socio-demographic variables and
pregnancy- and delivery complications (Table 2).
Measurements of fluctuations in symptoms of anxiety
between the two assessment points in gestational week
15 and 11 weeks postpartum showed no differences
either within or between the intervention group and the
control group. A total of 5% of women in the interven-
tion group and 4% of women in the control group had
symptoms of anxiety at all three assessment points. As
shown in Table 3, there was no difference in symptoms
of anxiety in relation to weight gain between the
intervention group and the control group at the time of
the different assessments. Neither was there any differ-
ence between the occurrence of anxiety symptoms
within the intervention and within the control group
(data not shown).
Depressive symptoms
There were no differences in the occurrence of symp-
toms of depression between the groups (Table 4).
A total of 18.7% of women in the intervention group
and 18.0% in the control group showed depressive
symptoms in early pregnancy (Table 4). In late preg-
nancy, the percentage of women with depressive symp-
toms was found to be 22.0% in the intervention group
and 17.5% in the control group. Postpartum the percen-
tages were 11.2% in the intervention group and 10.5% in
the control group.
Bivariate analyses showed that a lower level of educa-
tion was related to symptoms of depression in the inter-
vention group in gestational week 15 (p = .002) and in
gestational week 35 (p = .003). Similar results were
found in the control group in gestational week 35 (p =
.001). There was also a relationship between occupa-
tional status and depressive symptoms: in the interven-
tion group in gestational week 15 (p = .010), in the
control group in gestational week 35 (p = .001) and 11
weeks postpartum in both groups (p = .049 respectively
p = .017). Women who were unemployed showed more
symptoms of depression than women who were gain-
fully employed. Analyses within the groups showed a
significant relation in the control group between compli-
cations during pregnancy; i.e. diabetes, preeclampsia,
preterm contractions etc. and symptoms of depression
(p = .010). No such relationship could be found in the
intervention group. The multivariate analyses (logistic
r e g r e s s i o n )s h o wt h a tt h e r ewas no difference between
the intervention group and the control group after
Table 1 Symptoms of anxiety at gestational week 15 and 35, and 11 weeks postpartum
Intervention group Control group
Anxiety symptoms n % n % P*
Gestational week 15 .719
Absent** 114 75.5 142 77.2
Present*** 37 24.5 42 22.8
Gestational week 35 .648
Absent** 108 76.1 127 78.4
Present*** 34 23.9 35 21.6
Postpartum .557
Absent** 130 90.9 127 88.8
Present*** 13 9.1 16 11.2
*X
2 test
** Beck Anxiety Inventory (BAI) score <10
*** Beck Anxiety Inventory (BAI) score ≥10
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pregnancy- and obstetric complications
Gestational week 15 Gestational week 35 11 weeks postpartum
95% CI* for
OR**
95% CI* for
OR**
95% CI *for
OR**
p*** OR Lower Upper p*** OR Lower Upper p*** OR Lower Upper
Group Women in the intervention
group
Reference level Reference level Reference level
Women in the control group .399 .789 .454 1.369 .326 .739 .404 1.351 .651 1.213 .525 2.800
Parity Primipara Reference level Reference level Reference level
Multipara .805 .932 .534 1.628 .547 .829 .451 1.525 .283 1.618 .673 3.894
Smoking No Reference level Reference level Reference level
Yes .345 1.543 .627 3.795 .544 1.380 .488 3.896 .059 3.153 .956 10.403
Occupation Unemployed Reference level Reference level Reference level
Unskilled .302 .570 .196 1.657 .045 .284 .083 .973 .645 1.562 .234 10.410
Students/others .800 .881 .330 2.350 .460 1.498 .513 4.377 .293 2.578 .442 15.048
Skilled/lower white collar
workers
.064 .382 .138 1.056 .010 .217 .068 .696 .755 1.338 .214 8.363
Middle/high white collar workers .024 .239 .069 .826 .008 .160 .041 .622 .926 1.102 .144 8.409
Employment Gainfully employed Reference level Reference level Reference level
Not gainfully employed .224 1.597 .751 3.397 .928 .961 .399 2.312 .656 1.281 .431 3.808
Pregnancy
complication
No Reference level Reference level Reference level
Yes .014 1.983 1.147 3.430 .009 2.238 1.221 4.102 .664 1.202 .523 2.761
Delivery complication No Reference level Reference level Reference level
Yes .661 1.129 .656 1.944 .011 .436 .230 .824 .143 .499 .197 1.265
†Defined as score ≥10 in measurements with Beck Anxiety Inventory
* CI = Confidence Interval ** OR = Odds Ratio
***Statistical significance defined as p ≤ 0.05
Table 3 Symptoms of anxiety in relation to weight gain at gestational week 15 and 35 and 11 weeks postpartum
Weight gain during pregnancy <7 kg Weight gain during pregnancy >7 kg
Intervention group Control group Intervention group Control group
Anxiety symptoms n % n % p* n% n % p*
Gestational week 15 .441 .888
Absent** 39 76.5 25 80.6 69 76.7 96 77.4
Present*** 12 23.5 6 19.4 21 23.3 28 22.6
Gestational week 35 .688 .376
Absent** 34 75.6 21 77.8 68 77.3 87 78.4
Present*** 11 24.4 6 22.2 20 22.7 24 21.6
Postpartum .309 .877
Absent** 45 93.8 21 87.5 78 91.8 90 90.0
Present*** 3 6.2 3 12.5 7 8.2 10 10.0
*X
2 test
** Beck Anxiety Inventory (BAI) score <10
*** Beck Anxiety Inventory (BAI) score ≥10
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nancy- and delivery complications (Table 5).
Measurements of fluctuations in depressive symptoms
at the assessment points in gestational week 15 and 11
weeks postpartum showed no differences either within
or between the intervention group and the control
group. A total of 6% of women in the intervention
group and 4% of women in the control group had symp-
toms of depression at all three assessments. As shown in
Table 6, there was no difference in symptoms of depres-
sion in relation to weight gain in the intervention group
and the control group at the time of the different assess-
ments. Neither was there any difference between the
occurrence of depressive symptoms within the interven-
tion group and the control group (data not shown).
A total of six women in the intervention group (4.0%)
and three women in the control group (1.6%) had symp-
toms of both anxiety and depression at all three assess-
ment points.
Discussion
In this prospective intervention study with a primary
aim of minimizing gestational weight gain of obese
women, the prevalence of symptoms of anxiety and
depression during pregnancy varied between 18% and
25% within the intervention- and control group. The
postnatal prevalence of symptoms of anxiety and depres-
sion varied between 9% and 11% within these two
groups. No differences were found between the groups.
Around 4-5% of all women had symptoms of anxiety, 4-
6% had symptoms of depression and only a few women
presented symptoms of both anxiety and depression at
all three assessments. There was no relationship
between symptoms of anxiety, depression and weight
gain during pregnancy as measured on three different
occasions. In both groups, women with a lower level of
education and without employment showed symptoms
of anxiety and depression more often than women with
a higher level of education and gainful employment.
After adjustment for socio-demographic variables and
pregnancy, delivery and neonatal complications there
were no differences in the prevalence of symptoms of
anxiety between the groups. However, there was a rela-
tion between complications during pregnancy and symp-
toms of depression in the control group.
We hypothesized that participation in the intervention
program would increase psychological well-being due to
weekly motivational support and would therefore result
in a lower prevalence of anxiety or depressive symptoms
than would have resulted without the program. This
hypothesis was not confirmed. Neither did we find any
relation between weight gain during pregnancy or post-
natal weight and the prevalence of symptoms of anxiety
or depression among obese women in the intervention
group and the control group. One can consider whether
socioeconomic factors such as unemployment and or a
low level of education compose a stress on the indivi-
dual and the effect this has. It is possible, as suggested
by Britton [28], that mothers with a low level of educa-
tion may have a tendency towards developing high levels
of anxiety because they are less able to handle the
demands and expectations placed on them during the
period when they take on the maternal role. One may
also speculate if worrying about the future, as concerns
both employment and household economy, may lead to
symptoms of both anxiety and depression.
The prevalence of anxiety in a general population of
pregnant women during and after pregnancy has been
investigated in earlier studies [13,29,30]. In our study
t h ep r e v a l e n c eo fs y m p t o m so fa n x i e t ya m o n go b e s e
pregnant women was around 23% during pregnancy,
which is in accordance with findings by other authors
[13,30]. Breitkopf et al. assessed anxiety symptoms
among pregnant, non-pregnant and postnatal women,
Table 4 Depressive symptoms at gestational week 15 and 35 and 11 weeks postpartum
Intervention group Control group
Depressive symptoms n % n % p*
Gestational week 15 .882
Absent** 122 81.3 150 82.0
Present*** 28 18.7 33 18.0
Gestational week 35 .341
Absent** 110 78.0 132 82.5
Present*** 31 22.0 28 17.5
Postpartum .849
Absent** 127 88.8 128 89.5
Present*** 16 11.2 15 10.5
*X
2 test
** Edinburgh Postnatal Depression Scale (EPDS) score <10
*** Edinburgh Postnatal Depression Scale (EPDS) score ≥10
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pregnancy- and obstetric complications
Gestational week 15 Gestational week 35 11 weeks postpartum
95% CI* for
OR**
95% CI* for
OR**
95% CI* for
OR**
p*** OR Lower Upper p*** OR Lower Upper p*** OR Lower Upper
Group Women in the intervention
group
Reference level Reference level Reference level
Women in the control group .896 1.055 .469 2.376 .363 .673 .287 1.578 .650 1.235 .497 3.071
Parity Primipara Reference level Reference level Reference level
Multipara .022 2.825 1.160 6.880 .344 1.522 .638 3.634 .341 1.601 .607 4.225
Smoking No Reference level Reference level Reference level
Yes .077 2.722 .897 8.259 .070 3.038 .913 10.106 .111 2.882 .785 10.581
Occupation Unemployed Reference level Reference level Reference level
Unskilled .893 .909 .229 3.615 .174 .320 .062 1.650 .934 1.078 .184 6.328
Students/others .793 1.178 .347 4.000 .393 .535 .127 2.248 .503 1.707 .357 8.172
Skilled/lower white collar
workers
.053 .237 .055 1.019 .007 .093 .017 .518 .840 .839 .154 4.567
Middle/high white collar workers .102 .208 .032 1.362 .031 .121 .018 .821 .856 .836 .120 5.805
Employment Gainfully employed Reference level Reference level Reference level
Not gainfully employed .282 1.781 .622 5.105 .460 .622 .176 2.193 .198 2.110 .677 6.582
Pregnancy
complication
No Reference level Reference level Reference level
Yes .018 2.682 1.188 6.056 .003 3.825 1.576 9.285 .451 1.416 .574 3.494
Delivery complication No Reference level Reference level Reference level
Yes .696 .850 .377 1.919 .994 .997 .428 2.320 .745 .856 .334 2.193
†Defined as score ≥10 in measurements with Edinburgh Postnatal Depression Scale
* CI = Confidence Interval ** OR = Odds Ratio
***Statistical significance defined as p ≤ 0.05
Table 6 Depressive symptoms in relation to weight gain at gestational week 15 and 35 and 11 weeks post partum
Weight gain during pregnancy <7 kg Weight gain during pregnancy >7 kg
Intervention group Control group Intervention group Control group
Depressive symptoms n % n % p* n% n % p*
Gestational week 15 .378 .688
Absent** 45 88.2 26 81.2 71 79.8 100 82.0
Present*** 6 11.8 6 18.8 18 20.2 22 18.0
Gestational week 35 .153 .596
Absent** 33 75.0 24 88.9 73 83.0 88 80.0
Present*** 11 25.0 3 11.1 15 17.0 22 20.0
Postpartum .366 .387
Absent** 45 93.8 21 87.5 76 89.4 93 93.0
Present*** 3 6.2 3 12.5 9 10.6 7 7.0
*X
2 test
** Edinburgh Postnatal Depression Scale (EPDS) score <10
*** Edinburgh Postnatal Depression Scale (EPDS) score ≥10
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postnatal women in comparison with pregnant and non-
pregnant women even after controlling for depressive
symptoms [29]. This is in line with our results where
the symptoms of anxiety were lower postpartum than
during pregnancy. Nothing in our study indicates that
obese pregnant or postnatal women have more symp-
toms of anxiety than are exhibited in the general preg-
nant population.
Several studies have investigated the prevalence of
depressive symptoms during pregnancy and postpartum
[10,12,31-34]. The EDPS has been used with different
cut-offs for evaluating depressive symptoms
[10,12,31,33,34]. The prevalence in these studies varies
from 8% to 17% during pregnancy and 9% to 13% post-
partum. A study that used the same cut-off on the
EPDS for depressive symptoms as in this study found a
prevalence of depressive symptoms during late preg-
nancy and postpartum similar to what we found [10].
Furthermore, two studies have investigated the impact
of obesity on the risk for postpartum depression with
differing results [15,16]. In the study of LaCoursiere the
woman was asked to assess her depressive symptoms’
two - six months after delivery [15]. The five-level scale
was from “not depressed at all” to “very depressed and
had to get help”.A n s w e ro ns y m p t o m s ’ level ‘moder-
ately’ or more, indicated postnatal self-reported depres-
sion and was given by 31% of the obese women
postpartum [15]. In the study of Krause et al., where the
women completed the EPDS with a cut off of ≥13, six
weeks postpartum, a prevalence of 9% among over-
weight and obese women postpartum was shown [16].
Our results at the postnatal measurement were in accor-
dance with the findings in the study by Krause.
The relationship between antenatal and postnatal symp-
toms of depression has been investigated by Josefsson et
al. who showed that 6% of the women had symptoms both
during pregnancy and postpartum and this is in line with
our findings [10]. The occurrence of depressive symptoms
during and after pregnancy in relation to demographic
characteristics in a general pregnant population has also
been investigated [12,16,32,33,35]. These studies have
shown an association between economic difficulties, low
household income, unemployment, lower educational
attainment and depressive symptoms [12,16,32,33]. The
connection between anxiety and depressive symptoms and
maternal and neonatal outcome has been investigated
[36-38]. A review by Alder and colleagues found elevated
levels of anxiety and depression to be related to obstetric
complications, preterm labor and alleviation of labor pain
[36]. Vollebregt et al. investigated the association of pree-
clampsia and gestational hypertension with psychosocial
stress among nulliparous in the first half of pregnancy and
f o u n dt h a ta n x i e t y ,p r e g n a n c y - r e l a t e da n x i e t yo r
depression had no effect on the incidence of preeclampsia
and gestational hypertension [38]. Berle and co-authors
reported a relationship between anxiety disorder during
pregnancy and low Apgar score at one and five minutes,
but no relationship was observed with low birth weight or
preterm delivery [37]. We did not find any differences
between the two groups of women in our study regarding
the relationship between symptoms of anxiety and/or
depression and pregnancy-, delivery- and neonatal compli-
cations. In the control group, however, there was a rela-
tionship between pregnancy complications and depressive
symptoms at the assessment in late pregnancy.
This study was not randomized, which can be seen as
an important limitation. In all scientific research it is
important to control external factors and the environ-
ment has been found to exert a powerful influence on
people’s emotions and behavior [39] and careful consid-
eration must be given to ensure that the intervention
group and the control group will get treatment and care
at the same setting. We chose therefore to use ANCs in
two nearby cities to serve as controls. The antenatal
programs in Sweden are standardized and almost identi-
cal concerning the management of the pregnancy, which
ensures similar care at different ANCs. We were also
able to control for several background characteristics
that otherwise could confound the results. There was
also a difference in the completion rates between the
intervention- and control group. A total of five women
in the intervention group dropped out compared with
15 women in the control group. Another limitation is
that the number of questionnaires answered at the times
of the three assessments differs to some extent between
the intervention- and control group. Therefore some
caution is advisable when generalizing these results.
Furthermore, there are no data on prevalence of symp-
toms of anxiety and depression among women who
declined participation. Despite these limitations there
are some important findings in this study. To our
knowledge this is the first intervention study that has
investigated symptoms of anxiety and/or depression in
an obese pregnant population. Since there are few stu-
dies that have investigated the relation between anxiety
and depression among obese pregnant women especially
in relation to a weight gain intervention program there
is need for further work on this topic.
Conclusions
In conclusion, neither weight gain nor a weight gain
restriction program during pregnancy seems to influence
the prevalence of symptoms of anxiety or depression.
Obese women who participated in this study do not run
a higher risk for anxiety and/or depressive symptoms
during pregnancy or postpartum, compared with a gen-
eral pregnant and postnatal population.
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